Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
March 07 2024 - 4:05PM
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or
“Quoin”), a clinical stage specialty pharmaceutical company focused
on rare and orphan diseases, announced today that the Company plans
to release its fourth quarter and 2023 financial results after the
market closes on Wednesday, March 13, 2024.
The Company will host a conference call and
webcast at 8:30am ET on Thursday, March 14, 2024. The
call will include a discussion of fourth quarter and 2023 financial
results and a corporate update.
The live call can be accessed by dialing
1-800-603-0527 (domestic) or 1-412-317-0688 (international).
The live and archived webcast of the call will also be available
on the Quoin Pharmaceuticals website under the Investors section or
by following this link:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=ZmehVyN5
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a clinical stage
specialty pharmaceutical company focused on developing and
commercializing therapeutic products that treat rare and orphan
diseases. We are committed to addressing unmet medical needs for
patients, their families, communities and care teams. Quoin’s
innovative pipeline comprises four products in development that
collectively have the potential to target a broad number of rare
and orphan indications, including Netherton Syndrome, Peeling Skin
Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis
Bullosa and others. For more information,
visit: www.quoinpharma.com or LinkedIn for
updates.
For further information, contact:Investor
RelationsPCG AdvisoryStephanie Princesprince@pcgadvisory.com(646)
863-6341
Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From May 2024 to Jun 2024
Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Jun 2023 to Jun 2024